We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
83 hedge funds and large institutions have $468M invested in Regulus Therapeutics in 2014 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
617% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 6
370% more capital invested
Capital invested by funds: $99.5M → $468M (+$368M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
75% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 12
69% more funds holding
Funds holding: 49 → 83 (+34)
9% more call options, than puts
Call options by funds: $6.99M | Put options by funds: $6.42M
Holders
83
Holders Change
+34
Holders Change %
+69.39%
% of All Funds
2.21%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
43
Increased
21
Reduced
12
Closed
6
Calls
$6.99M
Puts
$6.42M
Net Calls
+$570K
Net Calls Change
+$514K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$70.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$40.4M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$33.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$16.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$14.4M |
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$10.6M |
| 2 |
Goldman Sachs
New York
|
-$3.14M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.31M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$1.26M |
